Singapore leads the Southeast Asian stock market after the approval of the Covid-19 vaccine

Singapore leads the Southeast Asian stocks after the approval of the Covid-19 vaccine

The Asia-Pacific stock market recorded mixed movements on December 14 trading after the decision to approve the circulation of Covid-9-resistant vaccines of some countries.

Singapore’s Straits Times Index led the rise in Southeast Asia with a 1.29% increase.

The green color on the Japanese stock market was maintained throughout the trading day of December 14 after news of the country’s business environment in the fourth quarter of 2020 was improved. The Nikkei 225 edged up 0.3% and closed at 26,732.44, while Topix rose 0.48% and closed the day with 1,790.52 points.

The recent Tankan survey – a quarterly economic survey conducted and published by the Central Bank of Japan, shows that Japan’s business sentiment in the fourth quarter of 2020 has improved. In particular, the sentiment index of large-scale manufacturers in the fourth quarter rose to -10, compared with -27 in September.

After hours of quiet trading in the morning session, mainland Chinese stocks this afternoon gained points and closed “green floor”. The Shanghai Composite Index increased 0.66% to 3,369.12 points, while the Shenzhen Component increased by 1.011% to 13,692.13 points. On the contrary, the Hong Kong stock market today did not escape the “red floor” with the Hang Seng index slipping 0.44% to 26,389.52 points.

Meanwhile, Singapore’s Straits Times index led the wave to rise in Southeast Asia with an increase of 1.29% to 2,858.14 points. On the same day, Singapore Prime Minister Ly Hien Long announced that the Health Science Agency of this country had approved the Covid-19-resistant vaccine co-produced by the pharmaceutical company Pfizer and BioNTech Biotechnology Company and the first batch of vaccine. It is expected to be shipped to the island nation later this month.

In addition, other Covid-19 resistant vaccines will be shipped to Singapore “in the coming months,” said the Prime Minister of Singapore. “If everything goes according to plan, we will have enough vaccines for everyone in Singapore by the third quarter of 2021,” said Singapore Prime Minister Ly Hien Long.

The above announcement was made by the head of the Government of Singapore in the context that this country recorded Covid-19 cases at a low level for many weeks.

In South Korea, the Kospi index slipped 0.28% as the country was facing a Covid-19 outbreak again, with the highest number of infections per day since the outbreak, according to Yonhap news agency.

Australian stocks recorded positive movements with the S & P / ASX 200 index rising 0.26% to 6,660.20 points. Overall, the MSCI Asia-Pacific (excluding Japan) still slipped slightly by 0.05% to 644.17 points.

Regarding the Covid-19 epidemic in the United States, Director of the Center for Disease Control and Prevention (CDC) Robert Redfield has officially approved the Covid-19-resistant vaccine produced by the pharmaceutical company Pfizer, and at the same time allowed Use this vaccine in people over 16 years old. Robert Redfield’s move came after the US Food and Drug Administration (FDA) issued an emergency license to Pfizer’s Covid-19 resistant vaccine.

From the morning of December 13, the US started to deploy the campaign to distribute Covid-19-resistant vaccines to hundreds of distribution centers nationwide.

In the money market, the greenback remains weak. The US dollar index against other major currencies continued to slide to 90,639, from 91. The Japanese Yen strengthened significantly and converted 103.81 JPY to “eat” 1 USD, compared to 104.4 JPY / USD established last week, while Australian dollar strengthened and traded 1 AUD for 0.756 USD, compared with 1 AUD / 0.749 USD of the previous week.

Oil traded in Asia this afternoon went up. Futures Brent oil inched up 0.8% to $ 50.37 / barrel, while crude oil delivered in the US rose by 0.75% and traded at $ 46.92 / barrel.

Design by NewsLax